These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 500322)

  • 1. Effect of oxipurinol and allopurinol riboside on whewellite crystallization: in vitro and in vivo observations.
    Finlayson B; Burns J; Smith A; Du Bois L
    Invest Urol; 1979 Nov; 17(3):227-9. PubMed ID: 500322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of allopurinol on calcium oxalate (whewellite) precipitation.
    Finlayson B; Reid F
    Invest Urol; 1978 May; 15(6):489-92. PubMed ID: 649299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Whewellite and weddellite: toward a different etiopathogenesis. The significance of morphological typing of calculi].
    Daudon M; Réveillaud RJ
    Nephrologie; 1984; 5(5):195-201. PubMed ID: 6531056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephrolithiasis: a consequence of renal epithelial cell exposure to oxalate and calcium oxalate crystals.
    Khan SR; Thamilselvan S
    Mol Urol; 2000; 4(4):305-12. PubMed ID: 11156696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of chromosome damage in human lymphocytes exposed to allopurinol and oxipurinol.
    Stevenson AC; Silcock SR; Scott JT
    Ann Rheum Dis; 1976 Apr; 35(2):143-7. PubMed ID: 942270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperuricosuria and calcium nephrolithiasis.
    Coe FL; Parks JH
    Urol Clin North Am; 1981 Jun; 8(2):227-44. PubMed ID: 7268958
    [No Abstract]   [Full Text] [Related]  

  • 7. [A study of crystallization on urolithiasis in vitro].
    Miyazawa K; Suzuki K; Tsugawa R
    Hinyokika Kiyo; 1991 Oct; 37(10):1091-6. PubMed ID: 1721765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of various modifiers on calcium oxalate crystallization.
    Kulaksizoglu S; Sofikerim M; Cevik C
    Int J Urol; 2007 Mar; 14(3):214-8. PubMed ID: 17430258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mechanism of formation of renal stone crystals.
    Nancollas GH
    Proc Eur Dial Transplant Assoc; 1983; 20():386-97. PubMed ID: 6361752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleation kinetics in the calcium oxalate-sodium urate monohydrate system.
    Meyer JL
    Invest Urol; 1981 Nov; 19(3):197-201. PubMed ID: 7298292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of takusha and kagosou on calcium oxalate renal stones in rats].
    Yamaguchi S; Jihong L; Utsunomiya M; Yoshioka T; Okuyama A; Koide T; Sugiyama K
    Hinyokika Kiyo; 1995 Jun; 41(6):427-31. PubMed ID: 7645450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymatic inhibition assay for fluorometric determination of allopurinol and oxipurinol in serum and urine.
    Neubert P; Besenfelder E; Koch K
    Arzneimittelforschung; 1980; 30(11):1857-9. PubMed ID: 6893932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro susceptibility testing of Naegleria fowleri to ketoconazole, BAYn7133, and allopurinol riboside.
    Smego RA; Durack DT
    J Parasitol; 1984 Apr; 70(2):317-8. PubMed ID: 6088750
    [No Abstract]   [Full Text] [Related]  

  • 14. Lack of inhibition by oxipurinol of 5-FU toxicity against human tumor cell lines.
    Garewal HS; Ahmann FR; Alberts DS
    Cancer Treat Rep; 1983 May; 67(5):495-8. PubMed ID: 6682703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleotide concentrations in hepatocytes during anoxia and reoxygenation in presence of allopurinol and oxypurinol.
    Schneider W; Grune T; Siems W; Werner A; Gerber G
    Biomed Biochim Acta; 1989; 48(2-3):S40-3. PubMed ID: 2730628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [14C-oxalate autoradiographic studies on distribution of oxalate and calcium oxalate crystal fixation in rat kidney].
    Ishii K; Sugimoto T; Kamikawa S; Kanazawa T; Nakatani T; Yamamoto K; Kishimoto T; Funae Y
    Hinyokika Kiyo; 1998 Apr; 44(4):245-51. PubMed ID: 9617620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystallization properties in urine from calcium oxalate stone formers.
    Tiselius HG; Bek-Jensen H; Fornander AM; Nilsson MA
    J Urol; 1995 Sep; 154(3):940-6. PubMed ID: 7637098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics and pathogenetic mechanisms in hyperuricosuric calcium oxalate renal stone disease.
    Favus MJ; Coe FL
    Scand J Urol Nephrol Suppl; 1980; 53():171-7. PubMed ID: 6937993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of nephrocalcin in inhibition of calcium oxalate crystallization and nephrolithiasis.
    Coe FL; Nakagawa Y; Asplin J; Parks JH
    Miner Electrolyte Metab; 1994; 20(6):378-84. PubMed ID: 7783700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of urinary bikunin in the inhibition of calcium oxalate crystallization.
    Atmani F; Khan SR
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S385-8. PubMed ID: 10541269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.